newsfilter
← Latest News
GlobeNewswire·

Phio Pharmaceuticals Reports 2023 Year End Financial Results and Provides Business Update

– Four sites across the country participating in clinical trial for lead product candidate PH-762 – Two patients have already completed treatment – New patent granted for skin related treatments, extending Phio's